e-ISSN: Pending
Failed Experiment ReportOpen accessComputer Science· cited by 30

Identification of Novel Cathepsin B Inhibitors with Implications in Alzheimer’s Disease: Computational Refining and Biochemical Evaluation

Nitin Chitranshi; Ashutosh Kumar; Samran Sheriff; Veer Bala Gupta; Angela Godinez; Danit Saks; Soumalya Sarkar; Ting Shen · 2021 · Cells

WASTE classifies this as Failed Experiment Report · AI classification, approximate

An experimental approach did not work as intended — learn what to avoid before investing the same effort.

Abstract

Amyloid precursor protein (APP), upon proteolytic degradation, forms aggregates of amyloid β (Aβ) and plaques in the brain, which are pathological hallmarks of Alzheimer's disease (AD). Cathepsin B is a cysteine protease enzyme that catalyzes the proteolytic degradation of APP in the brain. Thus, cathepsin B inhibition is a crucial therapeutic aspect for the discovery of new anti-Alzheimer's drugs. In this study, we have employed mixed-feature ligand-based virtual screening (LBVS) by integrating pharmacophore mapping, docking, and molecular dynamics to detect small, potent molecules that act a

Abstract by Nitin Chitranshi; Ashutosh Kumar; Samran Sheriff; Veer Bala Gupta; Angela Godinez; Danit Saks; Soumalya Sarkar; Ting Shen, Cells (2021) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.3390/cells10081946